Hammad R, Aglan R, Mohammed S, Awad E, Elsaid M, Bedair H
Int J Mol Sci. 2022; 23(20).
PMID: 36293412
PMC: 9604124.
DOI: 10.3390/ijms232012541.
Takeuchi T, Hirota Y, Nakagawa Y, Matsuoka A, Hamaguchi T, Okada Y
Diabetol Int. 2022; 13(1):226-231.
PMID: 35059259
PMC: 8733108.
DOI: 10.1007/s13340-021-00528-z.
Chockalingam A, Natarajan P, Thanikachalam P, Pandiyan R
Mo Med. 2021; 118(2):119-121.
PMID: 33840852
PMC: 8029630.
Koca A, Koca H, Anil C
Noise Health. 2021; 22(106):70-76.
PMID: 33402607
PMC: 8000137.
DOI: 10.4103/nah.NAH_41_20.
Kim S, Yun Y, Hur M, Moon H, Kim J
Korean J Lab Med. 2011; 31(1):22-9.
PMID: 21239867
PMC: 3111036.
DOI: 10.3343/kjlm.2011.31.1.22.
Newer forms of insulin.
Bohannon N
West J Med. 1983; 139(1):115-6.
PMID: 18749401
PMC: 1010916.
Statin use in the metabolic syndrome.
Lundbye J, Thompson P
Curr Atheroscler Rep. 2005; 7(1):17-21.
PMID: 15683597
DOI: 10.1007/s11883-005-0070-9.
Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-alpha) in normal and transgenic mice.
Braun A, Kwee L, Labow M, Alsenz J
Pharm Res. 1997; 14(10):1472-8.
PMID: 9358564
DOI: 10.1023/a:1012193326789.
Development and use of enzyme-linked immunosorbent assays (ELISA) for the detection of protein aggregates in interferon-alpha (IFN-alpha) formulations.
Braun A, Alsenz J
Pharm Res. 1997; 14(10):1394-400.
PMID: 9358552
DOI: 10.1023/a:1012168621337.
Determination of insulin specific IgE in serum of diabetic patients by solid-phase radioimmunoassay.
Falholt K
Diabetologia. 1982; 22(4):254-7.
PMID: 7047272
DOI: 10.1007/BF00281301.
Treatment of diabetes with insulin. From art to science.
Riddle M
West J Med. 1983; 138(6):838-46.
PMID: 6351440
PMC: 1010832.
Immunogenicity of recombinant DNA human insulin.
FINEBERG S, GALLOWAY J, Fineberg N, Rathbun M, Hufferd S
Diabetologia. 1983; 25(6):465-9.
PMID: 6198228
DOI: 10.1007/BF00284452.
Brittle diabetes--present concepts.
Gill G, Walford S, Alberti K
Diabetologia. 1985; 28(8):579-89.
PMID: 4054447
DOI: 10.1007/BF00281992.
Human insulin in the treatment of insulin allergy.
Lorenzi M, KARAM J
West J Med. 1985; 143(3):387-8.
PMID: 3901525
PMC: 1306341.
Differing effects of antiinsulin serum and antiinsulin receptor serum on 123I-insulin metabolism in rats.
SODOYEZ J, Sodoyez Goffaux F, von Frenckell R, de Vos C, Treves S, Kahn C
J Clin Invest. 1985; 75(5):1455-62.
PMID: 3889055
PMC: 425483.
DOI: 10.1172/JCI111848.
A case of diabetes mellitus associated with anti-insulin autoantibodies without previous insulin injection.
Sakata S, Nagai K, Imai T, Komaki T, Miura K
J Endocrinol Invest. 1987; 10(4):407-11.
PMID: 3316366
DOI: 10.1007/BF03348158.
Assessment of the antigenic response in humans to a recombinant mutant interferon beta.
KONRAD M, Childs A, Merigan T, Borden E
J Clin Immunol. 1987; 7(5):365-75.
PMID: 3308943
DOI: 10.1007/BF00917014.
Is quantitative assessment of insulin-antibodies and autoantibodies feasible?.
Koch M, SODOYEZ J, Dozio N, Di Silvio L, Kurtz A
Diabetologia. 1989; 32(11):774-8.
PMID: 2591646
DOI: 10.1007/BF00264906.
Sulfated beef insulin treatment elicits CD8+ T cells that may abrogate immunologic insulin resistance in type I diabetes.
Naquet P, Ellis J, Kenshole A, Semple J, Delovitch T
J Clin Invest. 1989; 84(5):1479-87.
PMID: 2530249
PMC: 304012.
DOI: 10.1172/JCI114323.
Hypoglycemias.
Service F
West J Med. 1991; 154(4):442-54.
PMID: 1877184
PMC: 1002792.
